8:59 AM ET
10-Q
Financial Results
Nika Pharmaceuticals Q3 2026 Results: Net Loss of $13K, Loss Widens
Nika Pharmaceuticals, Inc. reported a net loss of $46,077 for the nine months ended September 30, 2026, compared to a loss of $39,309 in the prior year period. The company remains in a pre-revenue stage with a total stockholders' deficit of $343,705 and is primarily funded through loans from related parties.
- Key figure
- Net loss $13K